Legend Biotech (LEGN) Change in Intangibles (2020 - 2023)
Legend Biotech (LEGN) reported Change in Intangibles of -$96000.0 for Q3 2023, down 110.51% on a YoY basis from $913000.0 in Q3 2022, and up 72.41% quarter-over-quarter from -$348000.0 in Q2 2023.
Legend Biotech (LEGN) Change in Intangibles (2020 - 2023) Analysis & Trends
Legend Biotech has reported Change in Intangibles for 4 years, with the latest figure at -$96000.0 in Q3 2023.
- For the quarter ending Q3 2023, Change in Intangibles fell 110.51% year-over-year to -$96000.0; the trailing twelve-month figure through Sep 2024 stood at -$96000.0 (up 93.52% YoY), and the FY2022 full-year result was -$1.3 million, up 57.97% from the prior year.
- Change in Intangibles for Q3 2023 stood at -$96000.0, up from -$348000.0 in the prior quarter.
- The five-year high for Change in Intangibles was $913000.0 in Q3 2022, with the low at -$4.0 million in Q4 2020.
- Historically, Change in Intangibles has averaged -$987076.9 across 4 years, with a median of -$654000.0 in 2021.
- Annual changes were most pronounced in 2021 — Change in Intangibles tumbled 528.33% — and 2022, when it surged 180.73%.
- Legend Biotech's Change in Intangibles stood at -$4.0 million in 2020, then grew by 20.4% to -$3.2 million in 2021, then jumped by 57.97% to -$1.3 million in 2022, then surged by 92.88% to -$96000.0 in 2023.
- The last three Change in Intangibles figures came in at -$96000.0 (Q3 2023), -$348000.0 (Q2 2023), and $310000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -96,000.00 |
| Sep 30, 2023 | -96,000.00 |
| Jun 30, 2023 | -348,000.00 |
| Jun 30, 2023 | -348,000.00 |
| Mar 31, 2023 | 310,000.00 |
| Mar 31, 2023 | 310,000.00 |
| Dec 31, 2022 | -1.35 Mn |
| Dec 31, 2022 | -1.35 Mn |
| Sep 30, 2022 | 913,000.00 |
| Sep 30, 2022 | 913,000.00 |
| Jun 30, 2022 | -881,000.00 |
| Jun 30, 2022 | -881,000.00 |
| Mar 31, 2022 | -411,000.00 |
| Mar 31, 2022 | -411,000.00 |
| Dec 31, 2021 | -3.21 Mn |
| Dec 31, 2021 | -3.21 Mn |
| Sep 30, 2021 | -1.13 Mn |
| Sep 30, 2021 | -1.13 Mn |
| Jun 30, 2021 | -654,000.00 |
| Jun 30, 2021 | -654,000.00 |